Feedback / Questions
nadunolimab (CAN04) - Cantargia
https://cantargia.com/en/press-releases/cantargia-granted-important-us-patent-for-nadunolimab
Aug 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next